Key Dates

Related Announcements

NOT-CA-22-037 - Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research

Issued by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

This Notice announces the participation of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in Funding Opportunity Announcement (FOA) NOT-CA-22-037, “Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research" effective immediately.

The following sections of NOT-CA-22-037 have been modified (changes shown in bold italics) to reflect the participation of NICHD in this FOA.

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Institute of Nursing Research (NINR)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Office of Behavioral and Social Sciences Research (OBSSR)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

IC Specific Application and Submission Information

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NICHD encourages research that addresses the institute’s Strategic Plan and is interested in the validation of digital health tools and AI technologies that have been developed or have the potential to be adopted and implemented in real-world settings across the life span for our population of interest (pregnant and lactating women, children, adolescent, and people with disabilities).

Appropriate topics include, but are not limited to the following validating technologies:

• Screening for children with developmental disorders, co-morbidities associated with IDD such as sleep apnea, obesity, and/or thyroid dysfunction
• Enhance prevention, diagnosis treatment and recovery of injury and illness in NICHD’s population of interest
• Support physical rehabilitation, health management, and community participation for people living in settings with limited resources and clinical support. This may include remote support of therapeutic exercise, assistive devices, periodic feedback on key clinical outcome measures, monitoring of progress, and interactive communication between therapists and the caregiver of the person.
• Improving transition of adolescents to adult healthcare providers by improving health literacy, enabling self-management and encouraging adherence to existing treatments among adolescents.
• Using digital health and/or AI technologies that monitor treatment related to adverse events, improvements, and outcomes in pregnant and lactating women, children, adolescent and people with disabilities
• Using digital technologies (e.g., Fitbit, accelerometer, digital pen) for collection of data on biometrics, sleep, physical activity, cognitive functions in population/epidemiological studies in pregnant and lactating women, children, adolescent, and people with disabilities
• Using digital technologies to evaluate the integration of health care transition processes (e.g., record transfer) and outcomes (e.g., transition completion) with electronic health records or other patient data (such as patient registries, data warehouses, billing data, pharmacy records, administrative records) at the point of care, including effective data sharing and care coordination.
• Using digital health and AI tool and technologies to better understand the uptake of HIV testing and other biomedical HIV prevention strategies, as well as improve the availability and accessibility of HIV services, among adolescents and young adults.
• For preconception health care and natural cycles in women including predicting and monitoring of menstrual cycle and hormone levels and ovulation
• For assessing men’s fertility through at-home technologies to track sperm function
• For image analysis and predicting embryo viability and live birth in IVF
• For digital health tools and AI algorithms to assess, monitor and mitigate risk for infertility disorders and treatments.
• For diagnosis and management of polycystic ovary syndrome.
• For digital health and/or AI technologies to monitor gynecologic health and/or screen/diagnose/treat gynecologic conditions including, but not limited to, endometriosis, uterine fibroids, gynecologic pain syndromes, and pelvic floor disorders.
• For digital health as well as AI tools and technologies to improve clinical decision-making and enhance/accelerate pediatric drug discovery and development, drug repurposing and clinical trials.

PIs are strongly encouraged to contact NICHD Scientific/Research staff well in advance of submitting applications to discuss the match to NICHD priorities and requirements.

NICHD’s FOAs for this NOSI include the following or their subsequent reissued equivalents:

Scientific/Research Contacts

Sujata Bardhan, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-0471
Email: [email protected]

All other aspects of the Notice remain unchanged.

Inquiries

Please direct all inquiries to:

Sujata Bardhan, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-0471
Email: [email protected]